Pharmaceutical Drug Export from Russia to North Korea (January – November 2017)
Russian export of pharmaceutical drugs is rather unstable, with some unusual destinations. In 2017, North Korea became one of the new export partners for Russia. Between January and November 2017, Russian export of drugs to North Korea increased by 3.7 times in monetary terms (in RUB) and by 5.2 times in physical terms (in units).
The total export volume is not that big, though. Between January and November 2017, Russia exported around 1.5 mln units of pharmaceuticals (see Chart 1) to North Korea, which is 28.6 mln RUB in monetary terms (including customs duties).
Russia exports more than 90 trademarks of drugs by 50 pharmaceutical companies. While the exports include drugs of foreign manufacturers, such as Baxter (Austria), Belmedpreparaty (Belarus) and Gedeon Richter (Hungary), most drugs are produced by Russian companies (93% of the volume in monetary terms).
The most exported drug Cocarboxylasum (in tablet form) by Bryntsalov-A accounts for more than 30% of export drugs, even though it was not exported in 2016. Piracetam, produced by 4 different companies, comes second, with its export volume having increased by 3.1 times over the past year. Ingalipt, Benzylpenicillinum, and Citramonum show the best progress, with a 22, 19.3, and 12.2 times increase, respectively.
However, manufacturers might not know where their products are exported because there are not any direct shipments. Between January and November 2017, shipments were handled by two exporting companies, with the Russian Best Pharm handling more than half of the shipments.
Chart 1. Volumes and dynamics of pharmaceutical drug export from Russia to North Korea (January – November 2017)
Tab 1. Top 10 trademarks in export volumes from Russia to North Korea (January – November 2017)